drugset / Trial / NCT01682460

Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients

NCT01682460 ↗

Phase 4 Completed 15 enrolled University of Waterloo Allergan · collab
NaSingle-groupOpen-labelTreatment

Summary

Research indicates that many people who are being treated for glaucoma have dry eyes. The purpose of this study is to test the use of artificial tears to alleviate dryness signs and symptoms in people who are using medication to treat glaucoma. The study hypothesis is that the use of artificial tears will result in an improvement in clinical signs and symptoms associated with dry eyes.

Timeline

Start
2012-08
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Refresh Tears Lubricant Eye Drops (Allergan) Unknown — Other